EP2276483
Föst form sem fela í sér (+)-2-[1-(3-etoxý-4-metoxýfenýl)-2-metýlsúlfónýletýl]-4-asetýlamínóísóindólín-1,3-d íón, blöndur þar af, og notkun þar af
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
27.3.2008EP published:
7.5.2014EP application number:
08742326.5
EP translation filed:
26.6.2014Grant published:
15.7.2014EPO information:
European Patent Register
Max expiry date:
26.3.2028Expiry date:
26.3.2018
Title:
SOLID FORMS COMPRISING (+)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLINE-1,3-DIONE, COMPOSITIONS THEREOF, AND USES THEREOF
Timeline
Today
27.3.2008EP application
7.5.2014EP Publication
26.6.2014Translation submitted
15.7.2014Registration published
26.3.2018Expires
Owner
Name:
Amgen (Europe) GmbHAddress:
Floor 6-8, Suurstoffi 22, 6343, Risch – Rotkreuz, , CH
Inventor
Name:
MULLER, George, W.Address:
Rancho Santa Fe, CA, US
Name:
SCHAFER, Peter, H.Address:
SomersetNJ, US
Name:
MAN, Hon-WahAddress:
PrincetonNJ, US
Name:
GE, ChuanshengAddress:
Belle MeadNJ, US
Name:
XU, JeanAddress:
WarrenNJ, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Supplementary protection
SPC number:
SPC126
Classification
Categories:
A61K 31/4035
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 3.3.2015
Expires: 26.3.2016
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 1.3.2016
Expires: 26.3.2017
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 2.3.2017
Expires: 26.3.2018
Payer: Sigurjónsson & Thor ehf.